Order Article Reprints

Rabaan AA, AlSaihati H, Bukhamsin R, Bakhrebah MA, Nassar MS, Alsaleh AA, Alhashem YN, Bukhamseen AY, Al-Ruhimy K, Alotaibi M, et al. Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current Oncology. 2023; 30(2):1954-1976. https://doi.org/10.3390/curroncol30020152

Rabaan, Ali A., Hajir AlSaihati, Rehab Bukhamsin, Muhammed A. Bakhrebah, Majed S. Nassar, Abdulmonem A. Alsaleh, Yousef N. Alhashem, Ammar Y. Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, and et al. 2023. "Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction" Current Oncology 30, no. 2: 1954-1976. https://doi.org/10.3390/curroncol30020152

Rabaan, A. A., AlSaihati, H., Bukhamsin, R., Bakhrebah, M. A., Nassar, M. S., Alsaleh, A. A., Alhashem, Y. N., Bukhamseen, A. Y., Al-Ruhimy, K., Alotaibi, M., Alsubki, R. A., Alahmed, H. E., Al-Abdulhadi, S., Alhashem, F. A., Alqatari, A. A., Alsayyah, A., Farahat, R. A., Abdulal, R. H., Al-Ahmed, A. H., ... Mohapatra, R. K. (2023). Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current Oncology, 30(2), 1954-1976. https://doi.org/10.3390/curroncol30020152